SLS Cash-Secured Put Strategy
SLS (SELLAS Life Sciences Group, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cancer. The company also develops nelipepimut-S, a cancer immunotherapy that targets human epidermal growth factor receptor 2, which is in Phase 2b clinical trials for the treatment of early-stage breast cancer. It has a strategic collaboration with Merck & Co., Inc. to evaluate GPS as it is administered in combination with PD1 blocker pembrolizumab in a Phase 1/2 clinical trial enrolling patients in up to five cancer indications, including hematologic malignancies and solid tumors. The company was founded in 2012 and is headquartered in New York, New York.
SLS (SELLAS Life Sciences Group, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $930.1M, a beta of 2.24 versus the broader market, a 52-week range of 1.39-6.72, average daily share volume of 6.3M, a public-listing history dating back to 2008, approximately 15 full-time employees. These structural characteristics shape how SLS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 2.24 indicates SLS has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a cash-secured put on SLS?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
Current SLS snapshot
As of May 15, 2026, spot at $7.06, ATM IV 150.40%, IV rank 33.98%, expected move 43.12%. The cash-secured put on SLS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.
Why this cash-secured put structure on SLS specifically: SLS IV at 150.40% is mid-range versus its 1-year history, so the credit collected on a SLS cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 43.12% (roughly $3.04 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated SLS expiries trade a higher absolute premium for lower per-day decay. Position sizing on SLS should anchor to the underlying notional of $7.06 per share and to the trader's directional view on SLS stock.
SLS cash-secured put setup
The SLS cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With SLS near $7.06, the first option leg uses a $6.50 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed SLS chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 SLS shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $6.50 | $0.75 |
SLS cash-secured put risk and reward
- Net Premium / Debit
- +$75.00
- Max Profit (per contract)
- $75.00
- Max Loss (per contract)
- -$574.00
- Breakeven(s)
- $5.75
- Risk / Reward Ratio
- 0.131
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
SLS cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on SLS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$574.00 |
| $1.57 | -77.8% | -$418.01 |
| $3.13 | -55.7% | -$262.02 |
| $4.69 | -33.6% | -$106.03 |
| $6.25 | -11.5% | +$49.96 |
| $7.81 | +10.6% | +$75.00 |
| $9.37 | +32.7% | +$75.00 |
| $10.93 | +54.8% | +$75.00 |
| $12.49 | +76.9% | +$75.00 |
| $14.05 | +99.0% | +$75.00 |
When traders use cash-secured put on SLS
Cash-secured puts on SLS earn premium while a trader waits to acquire SLS stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning SLS.
SLS thesis for this cash-secured put
The market-implied 1-standard-deviation range for SLS extends from approximately $4.02 on the downside to $10.10 on the upside. A SLS cash-secured put lets a trader earn premium while waiting to acquire SLS at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current SLS IV rank near 33.98% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on SLS should anchor more to the directional view and the expected-move geometry. As a Healthcare name, SLS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to SLS-specific events.
SLS cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. SLS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move SLS alongside the broader basket even when SLS-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on SLS carry tail risk when realized volatility exceeds the implied move; review historical SLS earnings reactions and macro stress periods before sizing. Always rebuild the position from current SLS chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on SLS?
- A cash-secured put on SLS is the cash-secured put strategy applied to SLS (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With SLS stock trading near $7.06, the strikes shown on this page are snapped to the nearest listed SLS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are SLS cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the SLS cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 150.40%), the computed maximum profit is $75.00 per contract and the computed maximum loss is -$574.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a SLS cash-secured put?
- The breakeven for the SLS cash-secured put priced on this page is roughly $5.75 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current SLS market-implied 1-standard-deviation expected move is approximately 43.12%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on SLS?
- Cash-secured puts on SLS earn premium while a trader waits to acquire SLS stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning SLS.
- How does current SLS implied volatility affect this cash-secured put?
- SLS ATM IV is at 150.40% with IV rank near 33.98%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.